Benedictine Health Center Of Minneapolis | |
618 East 17th Street, Minneapolis, Minnesota 55404 | |
(612) 879-2800 | |
Name | Benedictine Health Center Of Minneapolis |
---|---|
Location | 618 East 17th Street, Minneapolis, Minnesota |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 95 |
Occupancy Rate | 84.42% |
Medicare ID (CCN) | 245266 |
Legal Business Name | City Of Lakes Care Center |
Ownership Type | Non Profit - Corporation |
NPI Number | 1669478129 |
Organization Name | CITY OF LAKES CARE CENTER |
Doing Business As | BENEDICTINE HEALTH CENTER OF MINNEAPOLIS |
Address | 618 E 17th St, Minneapolis, MN 55404 |
Phone Number | 612-879-2811 |
News Archive
While the number of unemployed people with disabilities has slowly declined since May 2020, there is more to this picture.
A minimally invasive screening for ulcerative colitis, a debilitating gastrointestinal tract disorder, using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body, according to researchers at Georgia State University.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for Fentanyl Buccal tablets, USP, in the 0.1, 0.2, 0.4, 0.6 and 0.8 mg strengths, the generic equivalent to Cephalon's Fentora ® tablets.
Scientists at the University of Liverpool have developed a new technology which can dramatically improve the effectiveness of antibacterial treatments.
› Verified 2 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
While the number of unemployed people with disabilities has slowly declined since May 2020, there is more to this picture.
A minimally invasive screening for ulcerative colitis, a debilitating gastrointestinal tract disorder, using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body, according to researchers at Georgia State University.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for Fentanyl Buccal tablets, USP, in the 0.1, 0.2, 0.4, 0.6 and 0.8 mg strengths, the generic equivalent to Cephalon's Fentora ® tablets.
Scientists at the University of Liverpool have developed a new technology which can dramatically improve the effectiveness of antibacterial treatments.
› Verified 2 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $20930 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 11.8 | 14.46 |
Percentage of long-stay residents who lose too much weight | 5.32 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 45.92 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.68 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.28 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 2.33 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0.32 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.05 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 12.13 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 57.3 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 4.55 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 14.31 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 15.89 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 7.01 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.4 | 95.98 |
Percentage of short-stay residents who made improvements in function | 89.82 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 87.67 | 82.93 |
News Archive
While the number of unemployed people with disabilities has slowly declined since May 2020, there is more to this picture.
A minimally invasive screening for ulcerative colitis, a debilitating gastrointestinal tract disorder, using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body, according to researchers at Georgia State University.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for Fentanyl Buccal tablets, USP, in the 0.1, 0.2, 0.4, 0.6 and 0.8 mg strengths, the generic equivalent to Cephalon's Fentora ® tablets.
Scientists at the University of Liverpool have developed a new technology which can dramatically improve the effectiveness of antibacterial treatments.
› Verified 2 days ago
Walker Methodist Health Center Location: 3737 Bryant Avenue South, Minneapolis, Minnesota 55409 Phone: (612) 827-5931 | |
Mount Olivet Careview Home Location: 5517 Lyndale Avenue South, Minneapolis, Minnesota 55419 Phone: (612) 827-5677 | |
Fairview University Trans Serv Location: 2450 Riverside Avenue South, Minneapolis, Minnesota 55454 Phone: (612) 273-4197 | |
The Villa At Bryn Mawr Location: 275 Penn Avenue North, Minneapolis, Minnesota 55405 Phone: (612) 377-4723 | |
The Estates At Chateau Llc Location: 2106 Second Avenue South, Minneapolis, Minnesota 55404 Phone: (612) 874-1603 | |
Benedictine Health Center Of Minneapolis Location: 618 East 17th Street, Minneapolis, Minnesota 55404 Phone: (612) 879-2800 |